Beta
196429

EFFICACY OF INTRALESIONAL VERAPAMIL HYDROCHLORIDE VERSUS INTRALESIONAL TRIAMCINOLONE ACETONIDE IN HYPERTROPHIC SCARS AND KELOIDS

Article

Last updated: 24 Dec 2024

Subjects

-

Tags

Medicine

Abstract

Background: Keloids and hypertrophic scars are dermal fibro-proliferative disorders lead to disfigurement, pain and pruritus. Their management is still challenging as there is no universally accepted treatment regimen. Corticosteroid injections, most commonly triamcinolone acetonide, continue to play a major role in the management of keloids. Verapamil is a phenylalkylamine calcium channel blocker antiarrhythmic agent that has antifibrotic effect. Objective: To compare efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids. Patients and methods: Forty Egyptian patients with keloids or hypertrophic scars were divided into two equal groups. The patients were recruited from the Dermatology outpatient clinics of Al-Zahraa University Hospital during the period from May 2016 to May 2017. Informed written consents were obtained from all patients. Group A: Intralesional Verapamil Hydrochloride. Group B: Intralesional Triamcinolone Acetonide.      The efficacy of treatment was evaluated by Digital photography and Vancouver scar scale before and after treatment. Two- fine millimeter punch biopsies were taken from 5 patients of the verapamil group before and after treatment to demonstrate the histopathological changes induced by verapamil. Results: Both drugs improved total Vancouver scar scale, vascularity score and pliability score of keloid or hypertrophic scar nearly equally with no statistical significant difference. Both drugs improved height of keloid or hypertrophic scar significantly, but triamcinolone showed better improvement. Verapamil highly improved pigmentation score of keloids and hypertrophic scars, but triamcinolone showed non- significant improvement. Side effects were reported in 4 patients of triamcinolone group with no side effects in verapamil group.      The histopathological examination after treatment with verapamil injection showed marked reduction of collagen deposition and alteration of the fibroblast shape (from elongated to spherical), and these changes are similar to histopathological changes which occur after corticosteroids injection. Conclusion: Verapamil was among the several therapeutic modalities, have an option for keloids and hypertrophic scars with an extremely low cost and fewer adverse effects.

DOI

10.21608/amj.2021.196429

Keywords

keloids, hypertrophic scars, Verapamil, Triamcinolone

Authors

First Name

Radwa

Last Name

O. Mohamed

MiddleName

-

Affiliation

Department of Dermatology and Venereology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt

Email

radwa.tirana@yahoo.com

City

-

Orcid

-

First Name

Abeer

Last Name

M. Kamel

MiddleName

-

Affiliation

Department of Dermatology and Venereology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt

Email

-

City

-

Orcid

-

First Name

Osama

Last Name

M. Mostafa

MiddleName

-

Affiliation

Department of Pathology, Faculty of Medicine for Boys, Al-Azhar University, Cairo, Egypt

Email

-

City

-

Orcid

-

First Name

Nehal

Last Name

A. Gadallah

MiddleName

-

Affiliation

Department of Dermatology and Venereology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt

Email

-

City

-

Orcid

-

Volume

50

Article Issue

4

Related Issue

27826

Issue Date

2021-10-01

Receive Date

2021-09-27

Publish Date

2021-10-01

Page Start

2,887

Page End

2,900

Print ISSN

1110-0400

Link

https://amj.journals.ekb.eg/article_196429.html

Detail API

https://amj.journals.ekb.eg/service?article_code=196429

Order

46

Type

Original Article

Type Code

941

Publication Type

Journal

Publication Title

Al-Azhar Medical Journal

Publication Link

https://amj.journals.ekb.eg/

MainTitle

EFFICACY OF INTRALESIONAL VERAPAMIL HYDROCHLORIDE VERSUS INTRALESIONAL TRIAMCINOLONE ACETONIDE IN HYPERTROPHIC SCARS AND KELOIDS

Details

Type

Article

Created At

22 Jan 2023